Literature DB >> 10718597

Triclabendazole-resistant Fasciola hepatica in southwest Wales.

I Thomas, G C Coles, K Duffus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10718597

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  16 in total

1.  Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calves.

Authors:  Y Vera Montenegro; F Ibarra Velarde; E Liébano Hernández; H Quiroz Romero; R Castillo Bocanegra; A Hernández Campos; P Ochoa Galván
Journal:  Parasitol Res       Date:  2003-12-03       Impact factor: 2.289

2.  FhCaBP4: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domains.

Authors:  Rebecca Orr; Ruth Kinkead; Richard Newman; Lindsay Anderson; Elizabeth M Hoey; Alan Trudgett; David J Timson
Journal:  Parasitol Res       Date:  2012-07-08       Impact factor: 2.289

Review 3.  The global burden of fasciolosis in domestic animals with an outlook on the contribution of new approaches for diagnosis and control.

Authors:  Muhammad Kasib Khan; Muhammad Sohail Sajid; Hasan Riaz; Nazia Ehsan Ahmad; Lan He; Muhammad Shahzad; Altaf Hussain; Muhammad Nisar Khan; Zafar Iqbal; Junlong Zhao
Journal:  Parasitol Res       Date:  2013-06-01       Impact factor: 2.289

4.  Liver fluke β-tubulin isotype 2 binds albendazole and is thus a probable target of this drug.

Authors:  Emma Chambers; Louise A Ryan; Elizabeth M Hoey; Alan Trudgett; Neil V McFerran; Ian Fairweather; David J Timson
Journal:  Parasitol Res       Date:  2010-07-31       Impact factor: 2.289

5.  Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.

Authors:  M McConville; G P Brennan; M McCoy; R Castillo; A Hernandez-Campos; F Ibarra; I Fairweather
Journal:  Parasitol Res       Date:  2006-10-03       Impact factor: 2.289

6.  A deep exploration of the transcriptome and "excretory/secretory" proteome of adult Fascioloides magna.

Authors:  Cinzia Cantacessi; Jason Mulvenna; Neil D Young; Martin Kasny; Petr Horak; Ammar Aziz; Andreas Hofmann; Alex Loukas; Robin B Gasser
Journal:  Mol Cell Proteomics       Date:  2012-08-16       Impact factor: 5.911

7.  Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.

Authors:  S M Walker; B McKinstry; J C Boray; G P Brennan; A Trudgett; E M Hoey; H Fletcher; I Fairweather
Journal:  Parasitol Res       Date:  2004-10-28       Impact factor: 2.289

8.  The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

Authors:  Mark W Robinson; Alan Trudgett; Elizabeth M Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2003-08-09       Impact factor: 2.289

9.  A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.

Authors:  Simone A Beckham; David Piedrafita; Carolyn I Phillips; Nirma Samarawickrema; Ruby H P Law; Peter M Smooker; Noelene S Quinsey; James A Irving; Deanne Greenwood; Steven H L Verhelst; Matthew Bogyo; Boris Turk; Theresa H Coetzer; Lakshmi C Wijeyewickrema; Terry W Spithill; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

10.  Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica.

Authors:  H Solana; S Scarcella; G Virkel; C Ceriani; J Rodríguez; C Lanusse
Journal:  Vet Res Commun       Date:  2008-08-26       Impact factor: 2.459
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.